These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 3895397
1. 1,25-Dihydroxyvitamin D3-differentiated human promyelocytic leukaemia cells (HL-60) can kill antibody-coated tumour cells (K562). Espevik T. Scand J Immunol; 1985 Jul; 22(1):105-9. PubMed ID: 3895397 [Abstract] [Full Text] [Related]
2. 1 alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Tanaka H, Abe E, Miyaura C, Shiina Y, Suda T. Biochem Biophys Res Commun; 1983 Nov 30; 117(1):86-92. PubMed ID: 6581807 [Abstract] [Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. Mangelsdorf DJ, Koeffler HP, Donaldson CA, Pike JW, Haussler MR. J Cell Biol; 1984 Feb 30; 98(2):391-8. PubMed ID: 6319426 [Abstract] [Full Text] [Related]
4. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60. Inaba M, Okuno S, Nishizawa Y, Yukioka K, Otani S, Matsui-Yuasa I, Morisawa S, DeLuca HF, Morii H. Arch Biochem Biophys; 1987 Nov 01; 258(2):421-5. PubMed ID: 2823715 [Abstract] [Full Text] [Related]
5. Regulation of 25-hydroxyvitamin D3 metabolism in a human promyelocytic leukemia cell line (HL-60): 1,25-dihydroxyvitamin D3 stimulates the synthesis of 24,25-dihydroxyvitamin D3. Reichel H, Koeffler HP, Norman AW. Arch Biochem Biophys; 1986 Nov 15; 251(1):222-31. PubMed ID: 3024572 [Abstract] [Full Text] [Related]
6. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3. Miyaura C, Abe E, Suda T, Kuroki T. Cancer Res; 1985 Sep 15; 45(9):4244-8. PubMed ID: 2992776 [Abstract] [Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 induces a myelomonocytic phenotype with enhanced effector cell function in the HL-60 promyelocytic leukemia cell line. Rigby WF, Shen L, Ball ED, Fanger MW. Mol Immunol; 1985 May 15; 22(5):567-72. PubMed ID: 3860730 [Abstract] [Full Text] [Related]
9. Differentiated HL-60 promyelocytic leukaemia cells produce a factor inducing differentiation. Djulbegović B, Christmas SE, Moore M. Leuk Res; 1987 Nov 15; 11(3):259-64. PubMed ID: 3470575 [Abstract] [Full Text] [Related]
10. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism. Mavier P, Edgington TS. J Immunol; 1984 Apr 15; 132(4):1980-6. PubMed ID: 6321594 [Abstract] [Full Text] [Related]
11. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells. Koizumi T, Nakao Y, Ishizuka S, Oshida J, Hara N, Ikekawa N, Fijita T. Arch Biochem Biophys; 1990 Feb 01; 276(2):310-6. PubMed ID: 2407190 [Abstract] [Full Text] [Related]
12. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps. Inaba M, Okuno S, Koyama H, Nishizawa Y, Morii H. Arch Biochem Biophys; 1992 Feb 14; 293(1):181-6. PubMed ID: 1309983 [Abstract] [Full Text] [Related]
13. Reversibility of monocytic differentiation of HL-60 cells by 1alpha,25 dihydroxyvitamin D3. Tomoyasu S, Fukuchi K, Watanabe K, Ueno H, Hamano Y, Hisatake J, Hino K, Gomi K, Tsuruoka N. Leuk Res; 1997 Mar 14; 21(3):217-24. PubMed ID: 9111166 [Abstract] [Full Text] [Related]
14. Studies of the effect of 1,25-dihydroxycholecalciferol on the proliferation and differentiation of the human promyelocytic leukaemia cell line HL-60. Djulbegović B, Christmas SE, Evans G, Moore M. Biomed Pharmacother; 1986 Mar 14; 40(10):407-16. PubMed ID: 3472610 [Abstract] [Full Text] [Related]
15. Effects of uremic serum on 1,25-dihydroxyvitamin D3-induced differentiation of a human promyelocytic leukemia cell line, HL-60. Inaba M, Okuno S, Koyama H, Nishizawa Y, Morii H. J Nutr Sci Vitaminol (Tokyo); 1991 Dec 14; 37 Suppl():S93-103. PubMed ID: 1668175 [Abstract] [Full Text] [Related]
16. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate. Murao S, Gemmell MA, Callaham MF, Anderson NL, Huberman E. Cancer Res; 1983 Oct 14; 43(10):4989-96. PubMed ID: 6576856 [Abstract] [Full Text] [Related]
17. Metabolism of vitamin D in human promyelocytic leukemia cells (HL-60) II. Does the differentiation of the cells alter the metabolism? Imae Y, Shimizu M, Miyaura C, Suda T, Yamada S. Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1989 Oct 14; 23():73-80. PubMed ID: 2488967 [Abstract] [Full Text] [Related]
18. Modification of 1 alpha,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26,27,27,27-hexafluoro atoms in human promyelocytic leukaemia (HL-60) cells: isolation and identification of a novel bioactive metabolite, 26,26,26,27,27,27-hexafluoro-1 alpha,23(S),25-trihydroxyvitamin D3. Honda A, Nakashima N, Shida Y, Mori Y, Nagata A, Ishizuka S. Biochem J; 1993 Oct 15; 295 ( Pt 2)(Pt 2):509-16. PubMed ID: 8240250 [Abstract] [Full Text] [Related]
19. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones. Taoka T, Collins ED, Irino S, Norman AW. Mol Cell Endocrinol; 1993 Sep 15; 95(1-2):51-7. PubMed ID: 8243807 [Abstract] [Full Text] [Related]
20. Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea. Makishima M, Okabe-Kado J, Honma Y. Br J Cancer; 1998 Sep 15; 77(1):33-9. PubMed ID: 9459143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]